Ocular Therapeutix Inc
Change company Symbol lookup
Select an option...
OCUL Ocular Therapeutix Inc
OSAT Orbsat Corp
PEP PepsiCo Inc
DPZ Domino's Pizza Inc
KEY KeyCorp
AMH-F American Homes 4 Rent
LYB LyondellBasell Industries NV
CHD Church & Dwight Co Inc
ATHX Athersys Inc
PARR Par Pacific Holdings Inc
Go

Health Care : Pharmaceuticals | Small Cap Blend
Company profile

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. Its lead product candidate, DEXTENZA (dexamethasone insert) for intracanalicular use, has completed Phase III clinical development for the treatment of ocular pain and inflammation following ophthalmic surgery. OTX-TP (travoprost insert) is in Phase III clinical development for glaucoma and ocular hypertension. Its earlier stage assets include OTX-TIC, a sustained release travoprost intracameral injection for the treatment of moderate to severe glaucoma and ocular hypertension, as well as sustained release intravitreal injections for the treatment of retinal diseases. These injections include the development of OTX-TKI, a tyrosine kinase inhibitor, and, in collaboration with Regeneron an extended release protein-based anti-vascular endothelial growth factor trap.

Postmarket

Last Trade
Delayed
$7.91
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$7.91
Day's Change
0.30 (3.94%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
8.05
Day's Low
7.70
Volume
(Light)
Volume:
624,992

10-day average volume:
789,604
624,992
  • Prev Close
    7.61
  • Today's Open
    7.73
  • Day's Range
    7.70-8.05
  • Avg Vol (10-day)
    789.6K
  • Last (time)
    3:59p ET 10/01/20
  • Last (size)
    986
  • 52-Wk Range
    2.46 - 9.99
    LowHigh
  • (11/12/19 - 08/26/20)
    20.82%
  • 90.0%
  • Market Cap
    498.0M
  • Shares Outstanding
    63.0M
  • -1.98
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.4
  • 61.25
  • (% of float 09/15/20)
    11.27

Latest News

September 29, 2020
8:00 am ET
BusinessWire
September 10, 2020
7:00 am ET
BusinessWire
September 08, 2020
7:00 am ET
BusinessWire
September 04, 2020
7:00 am ET
BusinessWire
September 03, 2020
10:47 am ET
Globe Newswire
7:00 am ET
BusinessWire
August 07, 2020
7:15 am ET
BusinessWire
July 31, 2020
7:00 am ET
BusinessWire
July 23, 2020
7:00 am ET
BusinessWire
July 17, 2020
7:30 am ET
BusinessWire
July 16, 2020
8:19 am ET
Globe Newswire
July 15, 2020
7:00 am ET
BusinessWire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.